Access Bio, Inc.

Access Bio, Inc.

Access Bio, Inc.

Overview
Date Founded

2002

Headquarters

65 Cylde Road,Suite A,Somerset,Franklin, NJ 08873

Type of Company

Public

Employees (Worldwide)

65

Industries

Medical Products & Equipment
Biotechnology
Wholesale: Consumer Non-Durables/Sundries

Company Description

Access Bio, Inc. engages in the research, development, and manufacture of in-vitro diagnostic tests, biosensor, and molecular diagnostic products. The company was founded on September 27, 2002 and is headquartered in Franklin, NJ.

Executives & Employees

President, Chief Executive Officer & Director

Secretary

Board of Directors

President, Chief Executive Officer & Director at Access Bio, Inc.

Paths to Access Bio, Inc.
Potential Connections via
Relationship Science
You
Access Bio, Inc.
Recent Transactions
Details Hidden

Wooridul Pharmaceutical Ltd. purchases Access Bio, Inc.

Details Hidden

Access Bio, Inc. raised money in a private placement transaction

Details Hidden

Access Bio, Inc. issued KRW Ordinary Shares

Transaction Advisors
Underwriter

Advised onAccess Bio, Inc. issued KRW Ordinary Shares

Underwriter

Advised onAccess Bio, Inc. issued KRW Ordinary Shares

Clients

Partnership for Supply Chain Management, Inc. provides health care services. The company was founded in 1982 and is headquartered in Arlington, VA .

Key Stats and Financials As of 2019
Market Capitalization
$605M
Total Enterprise Value
$82.6M
Earnings Per Share
$-0.55
EBITDA
$-8.43M
Total Debt
$34.1M
Total Equity
$25M
Net Profit
$-15.8M
Revenue
$38.6M
Five Year Compounded Annual Growth Rate Of Revenue
5.94%
Three Year Compounded Annual Growth Rate Of Revenue
9.91%
Debt TEV
0.41x
TEVNet Income
-5.24x
Enterprise Value / Sales
2.14x
EBITDAMargin
-21.83%
Non-Profit Donations & Grants Received
Investors
Details Hidden

Daesung PE's investment strategy focuses on next-generation advanced technologies, providing funding and support for promising firms from the earliest stages and through various development stages. They offer continuous and comprehensive financing and extensive network support up to IPO.The firm invests in a range of industries within high tech. They look for small and mid-sized venture firms that have video-related operations and contents (movies and musicals), parts and materials, start-ups, as well as firms with a variety of games (online, mobile, video, and arcade).

Details Hidden

STIC Investments is a multi-strategy investment firm. They participate in private equity operations such as organic growth financing, recapitalization, buyouts or acquisition financing. They target primarily middle-market South Korean and Asian companies. The firm's deal flow leverages their network of Asian offices. They invest in technology companies across a broad spectrum of sub-sectors including mobile telecommunications, next-generation networks, biotechnology and robotics. Their exit strategies include M&A, trade sale and IPO.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Access Bio, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Access Bio, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Access Bio, Inc..